Biovitae

Salerno, Italy

Biovitae focuses on infection control and prevention, as well as combating antimicrobial resistance.

$5.7M raised

Apr 2025

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Biovitae raised?

Biovitae has raised $5.7M in total funding. The most recent round was Series A. The last funding was announced in April 2025.

Who are Biovitae's investors?

Biovitae's investors include Angelini Ventures, Ulixes Capital, Azimut Direct, ENEA Tech e Biomedical.

Where is Biovitae headquartered?

Biovitae is headquartered in Salerno, Italy.

What does Biovitae do?

Biovitae focuses on infection control and prevention, as well as combating antimicrobial resistance.

What stage is Biovitae at?

Biovitae is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 22, 2025.

MLA

"Biovitae — Funding & Investors." VCBacked, April 22, 2025, https://www.vcbacked.co/company/biovitae. Accessed July 2, 2026.

APA

VCBacked. (2025). Biovitae — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/biovitae

Wikipedia (cite web)

{{cite web |title=Biovitae — Funding & Investors |url=https://www.vcbacked.co/company/biovitae |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 22, 2025.